163 related articles for article (PubMed ID: 16291752)
1. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.
Noton EA; Colnaghi R; Tate S; Starck C; Carvalho A; Ko Ferrigno P; Wheatley SP
J Biol Chem; 2006 Jan; 281(2):1286-95. PubMed ID: 16291752
[TBL] [Abstract][Full Text] [Related]
2. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
[TBL] [Abstract][Full Text] [Related]
3. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
[TBL] [Abstract][Full Text] [Related]
4. The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin.
Bourhis E; Hymowitz SG; Cochran AG
J Biol Chem; 2007 Nov; 282(48):35018-23. PubMed ID: 17881355
[TBL] [Abstract][Full Text] [Related]
5. Differential subcellular localization of functionally divergent survivin splice variants.
Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
[TBL] [Abstract][Full Text] [Related]
6. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells.
Carvalho A; Carmena M; Sambade C; Earnshaw WC; Wheatley SP
J Cell Sci; 2003 Jul; 116(Pt 14):2987-98. PubMed ID: 12783991
[TBL] [Abstract][Full Text] [Related]
7. Distinct dynamics of Aurora B and Survivin during mitosis.
Delacour-Larose M; Molla A; Skoufias DA; Margolis RL; Dimitrov S
Cell Cycle; 2004 Nov; 3(11):1418-26. PubMed ID: 15483398
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
9. Survivin splice variants regulate the balance between proliferation and cell death.
Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA
Oncogene; 2005 Mar; 24(12):1994-2007. PubMed ID: 15688031
[TBL] [Abstract][Full Text] [Related]
10. Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody.
Vader G; Kauw JJ; Medema RH; Lens SM
EMBO Rep; 2006 Jan; 7(1):85-92. PubMed ID: 16239925
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
[TBL] [Abstract][Full Text] [Related]
12. Nuclear survivin has reduced stability and is not cytoprotective.
Connell CM; Colnaghi R; Wheatley SP
J Biol Chem; 2008 Feb; 283(6):3289-3296. PubMed ID: 18057009
[TBL] [Abstract][Full Text] [Related]
13. Survivin: a protein with dual roles in mitosis and apoptosis.
Wheatley SP; McNeish IA
Int Rev Cytol; 2005; 247():35-88. PubMed ID: 16344111
[TBL] [Abstract][Full Text] [Related]
14. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of S/G2 phase CDK4 reduces mitotic fidelity.
Burgess A; Wigan M; Giles N; Depinto W; Gillespie P; Stevens F; Gabrielli B
J Biol Chem; 2006 Apr; 281(15):9987-95. PubMed ID: 16476733
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
18. Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency.
Mull AN; Klar A; Navara CS
Stem Cell Res; 2014 Mar; 12(2):539-49. PubMed ID: 24487129
[TBL] [Abstract][Full Text] [Related]
19. Homodimerization antagonizes nuclear export of survivin.
Engelsma D; Rodriguez JA; Fish A; Giaccone G; Fornerod M
Traffic; 2007 Nov; 8(11):1495-502. PubMed ID: 17714426
[TBL] [Abstract][Full Text] [Related]
20. Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer.
Okamura K; Koike H; Sekine Y; Matsui H; Suzuki K
Cancer Epidemiol; 2009 Aug; 33(2):137-41. PubMed ID: 19679061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
